Crystal Structure and Mass Spectrometric Fragmentation Behavior of Eprosartan

Wu Jian-Mei,Wan Jie-Ping,Sun Cui-Rong
2009-01-01
Abstract:The crystal structure determination and mass spectrometric fragmentation analysis of the medicinal ingredient eprosartan (4-[2-butyl-5-(2-carboxy-3-thiophen-2-yl-propenyl)-imidazol-1-ylmethyl]-benzoic acid) are presented. The single-crystal X-ray diffraction shows that the colorless transparent crystal of eprosartan is of monoclinic system, space group P2/c with a = 16.1861(15), b = 10.9813(12), c = 28.610(3) angstrom, beta = 118.452(2)degrees, Z = 4, V = 4471.1(8) angstrom(3), D-c = 1.288 g/cm(3), mu(MoK alpha) = 0.178 mm(-1) and F(000) = 1831. The independent part of the unit cell contains two eprosartan molecules and one unordered H2O molecule in the crystal structure which is fixed by inter- and intramolecular hydrogen bonds. The product ions in electrospray ionization tandem mass spectrometry (ESI-MSn) displays the protonated eprosartan dissociated in three competitive pathways and the fragmentation mechanism is proposed and supported by the FTICR-MSn results.
What problem does this paper attempt to address?